GlassScriptPhysician profile
Aleem Surani
NPI 1689936502
$2,467.92
in general payments reported to CMS, 2019-2025
23 companies · $355 in 2025
The $355 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $950 · 2020: $222 · 2021: $162 · 2022: $217 · 2023: $68.99 · 2024: $493 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $571.21 | 2019-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $233.60 | 2019 | |
| Intuitive Surgical, INC. | $192.66 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $189.31 | 2019-2022 | |
| Allergan, INC. | $161.51 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $159.39 | 2019-2025 | Opsumit, Uptravi |
| Ceribell, INC. | $114.92 | 2022 | |
| Olympus America INC. | $113.25 | 2025 | Spiration Valve System, Single-Use Flexible Video Bronchoscope |
| Abbvie INC. | $109.77 | 2019-2022 | |
| Inspire Medical Systems, INC. | $105.42 | 2024 | Inspire |
| Veran Medical Technologies, INC. | $100.62 | 2019 | |
| Ekos Corporation | $86.06 | 2019 | |
| Amgen INC. | $71.26 | 2025 | Tezspire, Tavneos |
| Genentech USA, INC. | $58.47 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $37.63 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $24.97 | 2025 | Flexitouch Plus, Nimbl |
| Astrazeneca Pharmaceuticals LP | $23.73 | 2024 | Airsupra |
| Paratek Pharmaceuticals, INC. | $22.57 | 2020 | |
| Medtronic, INC. | $19.28 | 2022 | |
| Pulmonx Corporation | $19.13 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Breas Medical, INC. | $18.92 | 2023 | Vivo 45 Ls |
| Genzyme Corporation | $17.45 | 2024 | |
| Advanced Respiratory, INC | $16.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aleem Surani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.